ストックスクリーナーアプリを入手
28.56
12.22%
3.11
アフターアワーズ：
27.86
-0.70
-2.45%
Vyne Therapeutics Inc (VYNE) 最新ニュース
Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease - Business Wire
VYNE|Vyne Therapeutics Inc|Price:0.509|Chg%:-0.012 - TradingKey
Vyne Therapeutics Inc (VYNE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vyne Therapeutics Inc (VYNE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vyne Therapeutics Inc (VYNE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Vyne Therapeutics Provides Update Regarding C - Moomoo
Form 4 Vyne Therapeutics Inc For: 24 July By Investing.com - Investing.com South Africa
VYNE Therapeutics (Ticker: VYNE) CFO reports tax-share withholding event - Stock Titan
Tax withholding trims stake of VYNE Therapeutics Inc. (VYNE) CSO - Stock Titan
VYNE Therapeutics (VYNE) CLO has shares withheld for RSU taxes - Stock Titan
VYNE Therapeutics Inc. Revenue Breakdown – NASDAQ:VYNE - TradingView
Vyne Therapeutics Inc (VYNE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience - marketscreener.com
Press Release: VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger With Yarrow Bioscience - Moomoo
VYNE Therapeutics To Go Ex-Dividend On July 24th, 2026 With 0.40242 USD Special Dividend Per Share - Moomoo
Vyne Therapeutics set for 1-for-50 reverse stock split on July 24 - Bitget
VYNE Therapeutics (NASDAQ:VYNE) Draws Technical Attention After Reverse Split Update - Kalkine Media
Vyne Therapeutics Announces Aggregate Cash Div of $17.3M, or Abput $0.40242 Per Shr >VYNE - Moomoo
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split, $17.3M Special Dividend, and Merger with Yarrow Bioscience – Minichart - Minichart
VYNE Therapeutics approves 1-for-50 reverse stock split - Investing.com
VYNE Therapeutics approves 1-for-50 reverse stock split By Investing.com - Investing.com Australia
VYNE Therapeutics approves 1-for-50 reverse stock split ahead of Yarrow merger - MSN
VYNE Therapeutics Announces Reverse Split and Merger Plans - TipRanks
VYNE Therapeutics announces 1-for-50 reverse stock split - TipRanks
VYNE Announces 1-for-50 Reverse Stock Split, $17.3M Special Cash Dividend Ahead of Yarrow Merger - TradingView
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience - marketscreener.com
Press Release: VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection With the Proposed Merger With Yarrow Bioscience - Moomoo
VYNE Sets $17.3M Cash Dividend Before Expected Yarrow Merger - Stock Titan
VYNE Therapeutics Inc. Announces Merger with Yarrow Bioscience and Key Corporate Updates – SEC Form 8-K Filing July 2026 – Minichart - Minichart
VYNE Special Dividend Tied To Merger: My Take On The 8-K Learn (V8sbUVk4ib) - Mshale
Vyne Therapeutics holds shareholder special meeting on merger proposals - Bitget
VYNE Therapeutics (VYNE) investor reports 5.5M-share, 16.5% ownership stake - Stock Titan
VYNE Therapeutics (NASDAQ: VYNE) investors approve Yarrow merger - Stock Titan
Vyne Therapeutics Inc (NASDAQ: VYNE) Share Price, VYNE Stock News, VYNE Share Price & Updates - Kalkine
VYNE Therapeutics advances reverse merger with Yarrow Bioscience - TipRanks
VYNE Therapeutics Inc. (VYNE) reports 13.8% stake by Zhang Xiaofan - Stock Titan
VYNE Therapeutics (NASDAQ: VYNE) shares Yarrow transaction deck - Stock Titan
VYNE Therapeutics (NASDAQ: VYNE) outlines Yarrow merger, dividend terms - Stock Titan
Vyne Therapeutics Inc (VYNE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
VYNE Therapeutics (VYNE) Announces Special Dividend of $0.38 Ami - GuruFocus
VYNE Therapeutics Announces Special Cash Dividend in Connection With Pending Merger With Yarrow Bioscience - Moomoo
Vyne Therapeutics (NASDAQ:VYNE): What’s Behind the Special Dividend? - Kalkine Media
Vyne Therapeutics Declares Special Cash Divid - Moomoo
VYNE Announces Special Cash Dividend Ahead of Merger - GuruFocus
VYNE Therapeutics Inc. Declares Special Cash Dividend, Payable on July 23, 2026 - marketscreener.com
VYNE Therapeutics declares $16.5M dividend ahead of merger - Investing.com
VYNE Therapeutics Announces $16.5M Special Cash Dividend Ahead of Merger with Yarrow Bioscience - Minichart
VYNE Therapeutics declares $16.5M dividend ahead of merger By Investing.com - Investing.com Nigeria
VYNE declares special dividend ahead of Yarrow merger - TipRanks
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience - The Manila Times
VYNE Therapeutics declares $16.5M special cash dividend tied to Yarrow merger - TradingView
VYNE Therapeutics Announces Special Cash Dividend in Connection with Pending Merger with Yarrow Bioscience - Quiver Quantitative
VYNE Therapeutics (NASDAQ: VYNE) declares $0.38/share special dividend tied to merger - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
$16.5 million special payout for VYNE holders hinges on Yarrow merger vote - Stock Titan
VYNE stock holds its ground. Focus turns to the company profile. - Ad-hoc-news.de
VYNEVYNE Therapeutics Inc Forecast, Target Price - Finviz
VYNE SEC FilingsVyne Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Form 4 Vyne Therapeutics Inc For: 2 July By Investing.com - Investing.com Nigeria
VYNE Therapeutics (VYNE) CSO reports 2,370-share tax withholding on RSU vesting - Stock Titan
VYNE Therapeutics (VYNE) CLO has shares withheld to cover RSU taxes - Stock Titan
VYNE (VYNE) CEO Domzalski has 12,214 shares withheld for RSU taxes - Stock Titan
Price to book forward of VYNE Therapeutics Inc. – NASDAQ:VYNE - TradingView
Enterprise value to EBIT forward of VYNE Therapeutics Inc. – NASDAQ:VYNE - TradingView
Price to earnings forward of VYNE Therapeutics Inc. – NASDAQ:VYNE - TradingView
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):